SC 13G Filing

Company

Spyre Therapeutics, Inc.

Filed

December 1, 2023

Accession Number

0001493152-23-043412

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →